Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine

Clinical and Experimental Immunology

Volumn 142, Issue 2, 2005, Pages 377-380

  Porobič, J Martinuč ^a   Avcin T ^a   Božič, Borut ^b   Kuhar, M ^a   Cucnik S ^b   Zupancic M ^a   Prosenc, K ^c   Kveder, T ^b   Rozman, B ^b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Slovenia)

Author keywords

Autoimmunity; Hepatitis B; Vaccination

Indexed keywords

ANTINUCLEAR ANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; STUDENT; VACCINATION;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOIMMUNITY; BETA 2-GLYCOPROTEIN I; FEMALE; GLYCOPROTEINS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS COAGULATION INHIBITOR; MALE; VACCINATION; VACCINES, SYNTHETIC;

EID: 27644555939     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02923.x     Document Type: Article

References (20)

1. Blank M, Krause I, Fridkin M et al. Bacterial induction of autoantibodies to β2-glycoprotein I accounts for the infectious ethiology of the antiphospholipid syndrome. J Clin Invest 2002; 109:797-804.
2. Gharavi AE, Pierangeli SS, Espinola RG, Liu X, Colden-Stanfield M, Harris EN. Antiphospholipid antibodies induced in mice by immunization with cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo. Arthritis Rheum 2002; 46:545-52.
3. Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity - 'vaccinosis': a danger liaison? J Autoimmun 2000; 14:1-10.
4. Stegnar M, Božič B, Peternel P, Kveder T, Vene N, Rozman B. Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysis. Thromb Res 1991; 63:433-43.
5. Čučnik S, Ambrožič A, Božič B, Skitek M, Kveder T. Anti-beta2-glycoprotein I ELISA: methodology, determination of cut-off values in 434 healthy Caucasians and evaluation of monoclonal antibodies as possible international standards. Clin Chem Lab Med 2000; 38:777-83.
6. Avčin T, Ambrožič A, Božič B, Accetto M, Kveder T, Rozman B. Estimation of anticardiolipin antibodies, anti-beta2 glycoprotein I antibodies and lupus anticoagulant in a prospective longitudinal study of children with juvenile idiopathic arthritis. Clin Exp Rheumatol 2002; 20:101-8.
7. Bunn C, Kveder T. Counterimmunoelectrophoresis and immunodiffusion for the detection of antibodies to soluble cellular antigens. In: Van Venrooij WJ, Maini RN, eds. Manual of biological markers of disease. Dordrecht: Kluwer Academic Publishers, 1993; A3:1-12.
8. Maillefert JF, Sibilia J, Toussirot E et al. Rheumatic disorders developed after hepatitis B vaccination. Rheumatology 1999; 38:978-83.
9. Geier MR, Geier DA, Zahalsky AC. A review of hepatitis B vaccination. Exp Opin Drug Saf 2003; 2:113-22.
10. Borchers AT, Keen CL, Shoenfeld Y, Silva J, Gershwin ME. Vaccines, viruses, and voodoo. J Invest Allergol Clin Immunol 2002; 12:155-68.
11. Cervera R, Asherson RA, Acevedo ML et al. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis 2004; 63:1312-7.
12. Blank M, Shoenfeld Y. Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations. Clin Immunol 2004; 112:190-9.
13. Ordi-Ros J, Villarreal J, Monegal F, Sauleda S, Esteban I, Vilardell M. Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndrome. Clin Diagn Lab Immunol 2000; 7:241-4.
14. Sthoeger ZM, Fogel M, Smirov A et al. Anticardiolipin autoantibodies in serum samples and cryoglobulins of patients with chronic hepatitis C infection. Ann Rheum Dis 2000; 59:483-6.
15. Harada M, Fujisawa Y, Sakisaka S et al. High prevalence of anticardiolipin antibodies in hepatitis C virus infection: lack of effects on thrombocytopenia and thrombotic complications. J Gastroenterol 2000; 35:272-7.
16. Rahman F, Dahmen A, Herzog-Hauff S, Bocher WO, Galle PR, Lohr HF. Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen. Hepatology 2000; 31:521-7.
17. Borchers AT, Kuhl SJ, Keen CL, Meroni PL, Gershwin ME. Cytokines, chemokines, and their cognate receptors in autoimmune diseases. Sem Clin Immunol 1999; 18:17-39.
18. Hogenesch H, Azcona-Olivera J, Scott-Monterieff C, Snyder PW, Glickman LT. Vaccine-induced autoimmunity in the dog. Adv Vet Med 1999; 41:733-47.
19. Zhang H, Morgan-Capmer P, Latif N et al. Coxsackie virus B3-induced myocarditis. Characterisation of stable attenuated variants that protect against infection with cardiovirulent wild-type strain. Am J Pathol 1997; 150:2197-207.
20. Rose NR. Immunologic hazards associated with vaccination of humans. J Autoimmun 2000; 14:11-3.